secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0001493152-24-041133
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncocyte shareholders approve 1.25M share increase to equity plan
-----------------------------------------------------------------

- Stockholders approved Amended and Restated 2018 Equity Incentive Plan adding 1,250,000 shares, total pool now 2,300,000 shares.
- Vote: 8,469,172 for, 110,188 against, 8,410 abstained; 64.21% of voting power represented at special meeting on Oct 11, 2024.
- Amendments remove fungible share counting, eliminate share recycling restrictions, and remove one-year vesting minimum.
- Plan authorizes delegation of award grants to executive officers under Board-established limits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315224041133/0001493152-24-041133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315224041133/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer